Generic Name: Adalimumab
Brand Name: Humira
Manufacturer: AbbVie Corporation
Indications: Arthritis, Juvenile Idiopathic
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: July 18, 2013
Recommendation Type: List with clinical criteria and/or conditions